Recent Updates
Who's Online
Social Media & Digital Marketing (Article)
FDA Issues Guidance on Off-Label Drug Communications That May Impact Pharmaceutical Social Media Marketing
Tags:
On December 30, the U.S. Food and Drug Administration issued draft guidance focusing on how pharmaceutical companies should respond to unsolicited requests for off-label information about prescription drugs and medical devices. As of January 4, 2011, FDA is requesting public comment on the draft guidance document.
Read more »Ignite Health: Gamification of Healthcare
Tags:
Part of a Special Series on unNiched(micro) Scratch, Sniff and Learn Innovations
What is Cross-Channel Marketing?
Tags:
Part of a Special Series on Advanced Marketing and Measurement Techniques
Understanding How to Reach Customers Online, on Television, by Mail, E-mail and Other Media
Read more »AstraZeneca White Paper on Social Media Regulation and the Pharmaceutical Industry
Tags:
In February 2011, AstraZeneca released a white paper focusing on the Food and Drug Administration's regulation of digital and social media. The paper also focuses on how pharmaceutical companies like AstraZeneca can operate in the digital realm before and after FDA releases guidance on how drug firms should market their products online.
In addition, the paper provides and overview of AstraZeneca's opinion on how FDA should regulate social media communications:
Read more »